VNRX
Income statement / Annual
Last year (2023), VolitionRx Limited's total revenue was $775,302.00,
an increase of 153.04% from the previous year.
In 2023, VolitionRx Limited's net income was -$35.32 M.
See VolitionRx Limited’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$775,302.00
|
$306,392.00
|
$90,035.00
|
$13,433.00
|
$17,096.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$14,785.00
|
| Cost of Revenue |
$1.41 M |
$1.19 M |
$0.00 |
$0.00 |
$0.00 |
$639,916.00 |
$542,484.00 |
$309,406.00 |
$0.00 |
$0.00 |
| Gross Profit |
-$636,325.00 |
-$882,029.00 |
$90,035.00 |
$13,433.00 |
$17,096.00 |
-$639,916.00 |
-$542,484.00 |
-$309,406.00 |
$0.00 |
$14,785.00 |
| Gross Profit Ratio |
-0.82 |
-2.88 |
1 |
1 |
1 |
0 |
0 |
0 |
0 |
1 |
| Research and Development
Expenses |
$19.55 M
|
$14.57 M
|
$15.54 M
|
$14.53 M
|
$10.36 M
|
$10.91 M
|
$8.91 M
|
$6.84 M
|
$6.10 M
|
$4.04 M
|
| General & Administrative
Expenses |
$15.91 M
|
$16.11 M
|
$8.62 M
|
$5.47 M
|
$4.52 M
|
$5.78 M
|
$5.36 M
|
$5.43 M
|
$3.90 M
|
$1.91 M
|
| Selling & Marketing
Expenses |
$1.01 M
|
$1.05 M
|
$4.13 M
|
$1.07 M
|
$965,713.00
|
$1.17 M
|
$763,407.00
|
$347,712.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$16.92 M
|
$17.17 M
|
$12.75 M
|
$6.54 M
|
$5.49 M
|
$6.95 M
|
$6.13 M
|
$5.43 M
|
$3.90 M
|
$1.91 M
|
| Other Expenses |
$0.00 |
-$880,617.00 |
-$1.39 M |
-$447,680.00 |
$56,695.00 |
$37,233.00 |
$349,839.00 |
-$361,325.00 |
-$15,683.00 |
-$143,987.00 |
| Operating Expenses |
$36.76 M |
$30.86 M |
$26.90 M |
$20.63 M |
$15.90 M |
$17.90 M |
$15.05 M |
$11.91 M |
$9.86 M |
$5.81 M |
| Cost And Expenses |
$36.76 M |
$30.86 M |
$26.90 M |
$20.63 M |
$15.90 M |
$17.90 M |
$15.05 M |
$11.91 M |
$9.86 M |
$5.81 M |
| Interest Income |
$93,324.00 |
$125,265.00 |
$2,734.00 |
$49,495.00 |
$112,367.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$221,622.00 |
$173,087.00 |
$155,803.00 |
$129,799.00 |
$126,572.00 |
$110,924.00 |
$73,133.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$1.41 M
|
$1.19 M
|
$1.15 M
|
$1.04 M
|
$902,412.00
|
$639,916.00
|
$542,484.00
|
$309,406.00
|
$236,340.00
|
$142,131.00
|
| EBITDA |
-$34.04 M
|
-$29.24 M
|
-$25.69 M
|
-$19.23 M
|
-$15.07 M
|
-$17.26 M
|
-$14.15 M
|
-$11.60 M
|
-$9.96 M
|
-$8.07 M
|
| EBITDA Ratio |
-43.91 |
-95.42 |
-285.03 |
-1453.24 |
-881.5 |
0 |
0 |
0 |
0 |
-218.55 |
| Operating Income Ratio
|
-46.42
|
-103.72
|
-314.69
|
-1581.76
|
-938.4
|
0
|
0
|
0
|
0
|
-401.58
|
| Total Other
Income/Expenses Net |
$310,621.00
|
$1.18 M
|
$1.34 M
|
$848,521.00
|
-$56,131.00
|
-$110,924.00
|
-$73,133.00
|
$361,325.00
|
$470,873.00
|
-$2.28 M
|
| Income Before Tax |
-$35.68 M |
-$30.60 M |
-$26.99 M |
-$20.40 M |
-$16.10 M |
-$18.01 M |
-$14.77 M |
-$11.91 M |
-$9.53 M |
-$8.21 M |
| Income Before Tax Ratio
|
-46.02
|
-99.87
|
-299.77
|
-1518.6
|
-941.69
|
0
|
0
|
0
|
0
|
-555.53
|
| Income Tax Expense |
$0.00 |
-$329,676.00 |
-$19,313.00 |
$82,620.00 |
-$70,385.00 |
$110,924.00 |
-$276,706.00 |
-$361,325.00 |
-$4,604.00 |
$4.84 M |
| Net Income |
-$35.32 M |
-$30.27 M |
-$26.97 M |
-$20.48 M |
-$16.03 M |
-$18.01 M |
-$14.77 M |
-$11.91 M |
-$9.53 M |
-$8.21 M |
| Net Income Ratio |
-45.56 |
-98.79 |
-299.56 |
-1524.75 |
-937.57 |
0 |
0 |
0 |
0 |
-555.53 |
| EPS |
-0.5 |
-0.55 |
-0.51 |
-0.45 |
-0.41 |
-0.57 |
-0.56 |
-0.52 |
-0.54 |
-0.61 |
| EPS Diluted |
-0.5 |
-0.55 |
-0.51 |
-0.45 |
-0.41 |
-0.57 |
-0.56 |
-0.52 |
-0.54 |
-0.61 |
| Weighted Average Shares
Out |
$71.23 M
|
$55.35 M
|
$52.66 M
|
$45.28 M
|
$39.18 M
|
$31.39 M
|
$26.39 M
|
$23.05 M
|
$17.73 M
|
$13.44 M
|
| Weighted Average Shares
Out Diluted |
$71.23 M
|
$55.35 M
|
$52.66 M
|
$45.28 M
|
$39.18 M
|
$31.39 M
|
$26.39 M
|
$23.05 M
|
$17.73 M
|
$13.44 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
